Cargando…
Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex
The prevalence of lung disease caused by Mycobacterium abscessus is increasing among patients with cystic fibrosis. M. abscessus is a multidrug resistant opportunistic pathogen that is notoriously difficult to treat due to a lack of efficacious therapeutic regimens. Currently, there are no standard...
Autores principales: | Sullivan, Jaryd R., Yao, Jacqueline, Courtine, Christophe, Lupien, Andréanne, Herrmann, Jennifer, Müller, Rolf, Behr, Marcel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769517/ https://www.ncbi.nlm.nih.gov/pubmed/36342177 http://dx.doi.org/10.1128/spectrum.02672-22 |
Ejemplares similares
-
Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline
por: Sullivan, Jaryd R., et al.
Publicado: (2021) -
Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin a Using a Staphylococcus aureus Infection Model in Zebrafish Embryos
por: Fries, Franziska, et al.
Publicado: (2023) -
Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment
por: Graspeuntner, Simon, et al.
Publicado: (2023) -
Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
por: Mukherjee, Devika, et al.
Publicado: (2017) -
Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
por: Aziz, Dinah B., et al.
Publicado: (2018)